1.    国家自然科学基金面上项目，活性金属硼化物治疗痛性糖尿病周围神经病变的机制研究。项目号：82372122，2024.01-2027.12，资助金额48万，主持/在研

2.    国家自然科学基金面上项目，基于层状硼化物的糖调控系统用于糖尿病感染创面修复的研究。项目号：82172091，2022.01-2025.12，资助金额55万，主持/在研

3.    上海市“科技创新行动计划”优秀学术带头人计划，新型硼化物动态调控离子电流用于糖尿病神经疼痛的高效治疗。项目号：23XD1422800，2023.05-2026.04，资助金额40万，主持/在研

4.    上海市“科技创新行动计划” 生物医药支撑项目，“硼磁”糖尿病创面新型敷料研发。项目号：23S31900200，2023.04-2026.03，资助金额 25万，主持/在研

5.    上海市“东方英才青年计划” 2024.01-2026.12，资助金额 10万，主持/在研

6.    上海市基础项目子课题1项，化学动力学疗法的分子生物学功能及机制研究。项目号：19JC1412002。2019.11.01-2022.10.31，资助金额150万，主持/A结题

7.    国家自然科学基金青年项目1项，TLR2调节IL-33抵抗细菌感染的功能和机制研究。项目号：81202327。 2013.1-2015.12，资助金额23万，主持/结题

1.  国家自然科学基金面上项目，活性金属硼化物治疗痛性糖尿病周围神经病变的机制研究。项目号：82372122，2024.01-2027.12，资助金额48万，主持

2.   国家自然科学基金面上项目，基于层状硼化物的糖调控系统用于糖尿病感染创面修复的研究。项目号：82172091，2022.01-2025.12，资助金额55万，主持

3.  上海市“科技创新行动计划”优秀学术带头人计划，新型硼化物动态调控离子电流用于糖尿病神经疼痛的高效治疗。项目号：23XD1422800，2023.01-2025.12，资助金额40万，主持

4.  上海市“科技创新行动计划” 生物医药支撑项目，“硼磁”糖尿病创面新型敷料研发。项目号：23S31900200，2023.01-2025.12，资助金额 25万，主持

5.   上海市基础项目子课题1项，化学动力学疗法的分子生物学功能及机制研究。项目号：19JC1412002。2019.11.01-2022.10.31，资助金额150万，主持

6.   国家自然科学基金青年项目1项，TLR2调节IL-33抵抗细菌感染的功能和机制研究。项目号：81202327。 2013.1-2015.12，资助金额23万，主持

1.      Yang Chen#, Chaochao Wang#, Yelin Wu#, Ya Wang, Yun Meng, Fan Wu, Huilin Zhang, Yuen YeeCheng, Xingwu Jiang, Jieyun Shi, Huiyan Li, Peiran Zhao, Jinfeng Wu*, BinZheng, Dayong Jin*, Wenbo Bu*. Nutrient-Delivery and Metabolism ReactivationTherapy for Melanoma. 2024，Nature Nanotechnologydoi.org/10.1038/s41565-024-01690-6. IF 38.3

2.      Yun Meng#, Lijie Chen #, Yang Chen#, Jieyun Shi, ZhengZhang, Yiwen Wang, Fan Wu, Xingwu Jiang, Wei Yang, Li Zhang , Chaochao Wang,Xianfu Meng, Yelin Wu*, WenboBu* Reactive Metal Boride Nanoparticles Trap Lipopolysaccharide andPeptidoglycan for Bacteria-Infected Wound Healing. Nature communications, 2022,13(1):7353. IF 17.694

3.      Yelin Wu, Yanchun Quan, Yuanqi Liu, Keiwei Liu, HongquanLi, Ziwei Jiang, Tian Zhang, Hu Lei, K atherine A. Radek, Dongqing Li, ZhenhuaWang, Jilong Lu, Wang Wang, Shizhao Ji, Zhaofan Xia, Yuping Lai. Hyperglycemiainhibits REG3A expression to exacerbate TLR3-mediated skin inflammation indiabetes.Nature Communications,2016, 7:13393. IF 17.694

4.      Jiyue Wu, Yun Meng, Fan Wu, Jieyun Shi, Qingwen Sun,Xingwu Jiang, Yanyan Liu, Peiran Zhao, Qiao Wang, Lehang Guo, Yelin Wu*, Xiangpeng Zheng*, andWenbo Bu*. Ultrasound-driven Non-metallic Fenton-active Center Construction forExtensive Chemodynamic Therapy. Advanced Materials. 2023, 2307980. IF32.086

5.      Fan Wu, Yanli Li,Yun Meng, Xuechao Cai, Jieyun Shi,JinjinLi, Yang Chen, Li Zhang, Xianfu Meng, Huiyan Li, Xingwu Jiang, Zhenxiao Fu, YelinWu,* Wenbo Bu*. An Ion-enhanced Oncolytic Virus-like nanoparticle forTumor Immunotherapy. Angew. Chem. Int. Ed. 2022, e202210487. IF 16.823

6.      Zhongmin Tang, Shiman Wu, Peiran Zhao, Han Wang, DalongNi, Huiyan Li,Xingwu Jiang, Yelin Wu,* Yun Meng, Zhenwei Yao,*Weibo Cai, and Wenbo Bu*.Chemical Factory-guaranteed Enhanced ChemodynamicTherapy for Orthotopic Liver Cancer. Adv. Sci. 2022, 2201232.  IF 17.521

7.      Kun Wang, Jinjin Li, Yan Yi, Bin Lv, Yelin Wu*, ChaochaoWang, Huiyan Li, Yanli Li, Yang Liu,a Xuechao Cai,  Xianfu Meng, Xingwu Jiang, Xiangpeng Zheng,*Zhaocai Zhou, and Wenbo Bu*. Polyamine-activated carbonyl stress strategy foroxidative damage therapy. Nano Today. 42 (2022) 101355. IF 18.962

8.      Hu Lei, Yue Wang, Tian Zhang, Leilei Chang, *Yelin Wu, *Yuping Lai.TLR3activation induces S100A7to regulate keratinocyte differentiation after skin injury. SCIENCE CHINA Life Sciences. 2017 Feb; 60(2):158-167.  IF 10.372

9.      Yelin Wu, Yanli Li, Guanglei Lvand Wenbo Bu. Redox dyshomeostasis strategy for tumor therapy based onnanomaterials chemistry. DOI: 10.1039/d1sc06315d.Chemical Sci. 2022 Feb 23; 13(8): 2202-2217.IF 9.969

10.   Xuechao Cai#, Xiaogang Bao#, Yelin Wu.* Metal–Organic Frameworks as Intelligent DrugNanocarriers for Cancer Therapy. Pharmaceutics 2022, 14(12), 2641. Doi:org/10.3390/pharmaceutics14122641.IF 6.525

11.   Xianfu Meng, *Yelin Wu, and *Wenbo Bu.Functional CT Contrast Nanoagents for the Tumor Microenvironment. AdvancedHealthcare Materials. 2020; 2000912. IF 11.092.

12.    Yanli Li, Peiran Zhao, Teng Gong*, Han Wang, XingwuJiang, Hui Cheng, Yanyan Liu, Yelin Wu*, Wenbo Bu* RedoxDyshomeostasis Strategy for Hypoxic Tumor Therapy Based on DNAzyme‐LoadedElectrophilic ZIFs. 2020. Angew. Chem. Int. Ed. 2020Dec7;59(50):22537-22543.IF 16.823

13.   Weiwei Su, Han Wang, Tao Wang, Xiao Li, Zhongmin Tang,Shuai Zhao, Meng Zhang, Danni Li, Xingwu Jiang, Teng Gong, Wei Yang, ChangjingZuo,* Yelin Wu,* Wenbo Bu*. Auger Electrons Constructed ActiveSites on Nanocatalysts for Catalytic Internal Radiotherapy. AdvancedScience. 2020.7.1903585. IF 17.521

14.    Li Qin#, Ye-linWu#, Michael J. Toneff, Dabing Li, Lan Liao, Xiuhua Gao, Jean C-Y. Tien, Yixiang Xu, Zhen Feng, Suoling Zhou, Yi Li, andJianming Xu. NCOA1 directly targets M-CSF1 expression to promote breast cancermetastasis. Cancer Res.  2014 Jul 25;74(13):3477-88  IF 13.312